On June 8, 2010
Lilly’s Plan to Launch “Branded Generic” Drugs: A Blueprint for Lower Profits
Eli Lilly (LLY) is going into “branded generics,” just like Pfizer (PFE) and Abbot Labs (ABT). In theory, this is an attractive idea. Consumers may well want to pay a premium for Lilly’s version of Cialis rather than a generic
…
0 Comments